V012-5025 Screening compound: 2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one

V012-5025 Screening compound: 2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one
V012-5025 Screening compound: 2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-5025
2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-5025

Molecular Formula

C25H24ClFN2O2 (C25 H24 ClFN2 O2)

Compound Name

2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one

IUPAC name

2-(4-chlorophenoxy)-1-{4-[(4-fluorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-one

SMILES

O=C(COc(cc1)ccc1Cl)N(CC1)CCN1C(c1ccccc1)c(cc1)ccc1F

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

438.93

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.763

Distribution Coefficient, logD

4.762

Water Solubility, LogSw

-5.23

Polar Surface Area

26.420

Acid Dissociation Constant (pKa)

24.59

Base Dissociation Constant (pKb)

4.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

V012-5025 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • GPCR
  • Ion Channels
  • Proteases

References: we are preparing a list of scientific research reports with V012-5025 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-5025?
Check Price and Availability of V012-5025, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-5025 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-5025
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-5025
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-5025 available by request